GLP-1 side effects and results: what TikTok gets wrong

What did @maggienowka_ actually say?

Straightforwardly: nothing about GLP-1 medications, weight loss, or health at all. The transcript is entirely song lyrics, something along the lines of "you make a mild dream come true" repeated over what sounds like a backing track. There are no health claims, dosing tips, testimonials, or product mentions anywhere in the 2.1K-view video. This is a music video or lip-sync post, full stop.

That matters for fact-checking purposes because there is genuinely nothing to fact-check. No claim was made. No advice was given. The creator did not speak about semaglutide, tirzepatide, liraglutide, or any GLP-1 receptor agonist. Tagging a video as GLP-1 content does not make it GLP-1 content.

Does the science back this up?

There is no scientific claim in this video to evaluate. The lyrics do not reference pharmacology, appetite suppression, insulin secretion, or any mechanism associated with GLP-1 receptor agonists. Applying clinical literature here would be a category error.

That said, the broader context is worth naming. TikTok is a real vector for GLP-1 misinformation. A 2023 analysis by Knoepflmacher and colleagues in Obesity Medicine found that the most-viewed TikTok videos about Ozempic frequently omitted side effect information and exaggerated weight loss outcomes. The platform's categorization of content as health-adjacent, even when it is not, can subtly shape how audiences perceive the topic. A song tagged under GLP-1 content contributes to a noisy information environment, even if unintentionally.

What did they get wrong (or right)?

The creator got nothing medically wrong, because they said nothing medical. That is genuinely the correct verdict here. Credit where it is due: this video does not spread misinformation about compounded semaglutide, does not make weight loss promises, and does not recommend a dosing protocol. On those metrics, it outperforms a meaningful share of actual GLP-1 content on the platform.

What is worth flagging is the categorization problem. If this video was tagged or surfaced as GLP-1 content by the platform or the creator, that is a metadata issue, not a clinical one. Audiences searching for information about Wegovy or Zepbound and landing on a lip-sync video are not being harmed directly, but they are not being helped either. The signal-to-noise ratio in telehealth-adjacent social media is already poor. Miscategorized content makes it worse.

What should you actually know?

If you ended up reading a fact-check of a song because you were looking for GLP-1 information, here is what is actually worth your time. GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are FDA-approved medications with real clinical evidence behind them. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide producing up to 22.5% mean body weight reduction over 72 weeks in adults with obesity.

These are also medications with real side effect profiles, including nausea, vomiting, gastroparesis risk, and potential thyroid concerns. They require clinical oversight. Compounded versions of these drugs are not equivalent to brand-name formulations and are not FDA-approved. Anyone telling you otherwise on TikTok, in a song or otherwise, is either wrong or selling something.

• GLP-1 medications require a prescription and ongoing medical supervision.
• Compounded semaglutide is not the same as Wegovy or Ozempic.
• Side effects are real and should be discussed with a licensed provider.
• Social media content tagged as health content is not regulated for accuracy.